Among these potential targets, PPARα, a key nuclear receptor that promotes β-oxidation, was markedly decreased in both WD-induced steatosis mice (Figure 3A) and WD/CCl4-induced NASH mice (Figure 3B), while bicyclol with or without berberine increased its expression. This evidence concerns the gene PPARA and Wilson disease.